Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Chung Shan Medical University
  3. Pure學術人才庫轉入
  4. Induction of plasminogen activators in pregnant women with Toxoplasma gondii infection
 
  • Details
Options

Induction of plasminogen activators in pregnant women with Toxoplasma gondii infection

Journal
Clinical and Experimental Obstetrics and Gynecology
Date Issued
2011-01-01
Author(s)
KE-MIN CHEN  
SHIH-CHAN LAI  
URI
https://www.scopus.com/pages/publications/84863039077
https://scholars.csmu.edu.tw/handle/123456789/27199
Abstract
Objective: To determine whether plasminogen activators (PAs) are involved in the pathologic process of toxoplasmosis. Materials and Methods: Out of 220 pregnant women the study included 26 with a diagnosis of toxoplasmosis: six based on seropositivity for Toxoplasma gondii IgM and 20 based on seropositivity for T. gondii IgG. We measured serum activities and protein levels of PAs by casein zymography and Western blotting, respectively. Results: Serum PAs were higher in healthy pregnant women than in their healthy nonpregnant counterparts. Furthermore, serum PAs were significantly higher in pregnant women infected with T. gondii than in their healthy counterparts. Conclusion: PAs participate in the pathogenesis of toxoplasmosis in pregnant women and may be useful markers of T. gondii infection.
Type
journal article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback